Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
MRNA compared with RNA: revenue, margins and what each company keeps, and the suppliers and customers both name
MRNA
Moderna, Inc.
Change
Mkt cap
Revenue
Revenue
RNA
Atrium Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
MRNA
Moderna, Inc.
vs
RNA
Atrium Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
RNA: latest quarter is a loss; flow not drawable.
Method
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
MRNA, solid
RNA, dashed
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only MRNA
12
MRK
Merck
customer
VRTX
Vertex Pharmaceuticals
customer
PSNL
Personalis
supplier
ABUS
Arbutus Biopharma
supplier
8 more · MRNA chain
›
Shared
0
No disclosed counterparties: RNA.
Only RNA
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
MRNA
Moderna, Inc.
Change
260.75
▲
+7.99%
· post 256.94
Mkt cap
$102.9B
Revenue
$1.3B
Q3 FY26
Revenue
$1.9B
FY25
RNA
Atrium Therapeutics, Inc.
Change
8.38
▲
+0.72%
· post 8.38
Closed
Nov 6 '26
Mkt cap
$142.7M
Revenue
$3M
Q2 FY26
Revenue
—
vs
Compare
Closed
Nov 6 '26
MRNA
Moderna, Inc.
vs
RNA
Atrium Therapeutics, Inc.
260.75
▲
+7.99%
post 256.94
Price
8.38
▲
+0.72%
post 8.38
$102.9B
Mkt cap
$142.7M
Q3 FY26
$1.3B
Revenue
$3M
Q2 FY26
FY25
$1.9B
Revenue
—
Change
Change
MRNA
260.75
▲
+7.99%
vs
RNA
8.38
▲
+0.72%
Closed
Nov 6 '26